Personalised Regional Modelling Predicts Tau Progression in the Human Brain
Authors:
- Pavanjit ChaggarPCPavanjit Chaggar
- Jacob W VogelJVJacob W Vogel
- Alexa Pichet BinetteABAlexa Pichet Binette
- Travis B. ThompsonTTTravis B. Thompson
- Niklas Mattsson-CarlgrenNMNiklas Mattsson-Carlgren
- Linda KarlssonLKLinda Karlsson
- Saad JbabdiSJSaad Jbabdi
- The Alzheimer’s Disease Neuroimaging InitiativeTIThe Alzheimer’s Disease Neuroimaging Initiative
Preprint
Abstract
Aggregation of the hyperphosphorylated tau protein is a central driver of Alzheimer’s disease, and its accumulation exhibits a rich spatio-temporal pattern that unfolds during the course of the disease, sequentially progressing through the brain across axonal connections. It is unclear how this spatio-temporal process is orchestrated – namely, to what extent the spread of pathologic tau is governed by transport between brain regions, local production or both. To address this, we develop a mechanistic model from tau PET data to describe tau dynamics along the Alzheimer’s disease timeline. Our analysis reveals longitudinal changes in production and transport dynamics on two independent cohorts, with subjects in early stage of the disease exhibiting transport-dominated spread, consistent with an initial spread of pathologic tau seeds, and subjects in late stage disease (Braak stage 3/4 onwards) characterised primarily by local production of tau. Furthermore, we demonstrate that the model can accurately predict subject-specific longitudinal tau accumulation at a regional level, potentially providing a new clinical tool to monitor and classify patient disease progression. Teaser: A mechanistic model reveals tau protein dynamics in Alzheimer’s, showing stage-specific shifts in transport and local production.Keywords
All Related Versions
- Published version: PLOS Biology, 23 (7), e3003241.
This publication has 60 references indexed in Scilit:
- Correlating tau pathology to brain atrophy using a physics-based Bayesian modelEngineering with Computers, 2022
- Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative DisordersJAMA Neurology, 2020
- Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative DisordersJAMA, 2020
- Staging β-Amyloid Pathology With Amyloid Positron Emission TomographyJAMA Neurology, 2019
- Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948European Journal of Nuclear Medicine and Molecular Imaging, 2019
- The basis of cellular and regional vulnerability in Alzheimer’s diseaseActa Neuropathologica, 2019
- Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer DiseaseJAMA Neurology, 2017
- In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrumAnnals of Neurology, 2016
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's diseaseNeuron, 1989